Syngene International Limited (BOM: 539268)
India flag India · Delayed Price · Currency is INR
844.65
-5.05 (-0.59%)
At close: Dec 20, 2024

Syngene International Company Description

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing and sterile fill-finish services.

It also provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services.

In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization.

It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies.

The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India.

Syngene International Limited is a subsidiary of Biocon Limited.

Syngene International Limited
Country India
Founded 1993
Industry Commercial Physical and Biological Research
Employees 6,510
CEO Jonathan Hunt

Contact Details

Address:
Velankani Technology Park
Bengaluru, Karnataka 560100
India
Phone 91 80 6891 9191
Website syngeneintl.com

Stock Details

Ticker Symbol 539268
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 8731

Key Executives

Name Position
Jonathan Hunt Chief Executive Officer
Deepak Jain Chief Financial Officer
Krishnan G Head of Investor Relations